Aluminum Phosphate-Adjuvanted Clade C gp140

gp140 with aluminum phosphate adjuvant · Janssen Vaccines & Prevention B.V.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Aluminum Phosphate-Adjuvanted Clade C gp140, covering 2023-04-18 to 2023-04-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Efficacy of a Heterologous Prime/Boost Vaccine Regimen of Ad26.Mos4.HIV and Aluminum Phosphate-Adjuvanted Clade C gp140 in Preventing Human Immunodeficiency Virus (HIV) -1 Infection in Women in Sub-Saharan Africa [Phase 2]

See pricing